Upgrade to SI Premium - Free Trial

Puma Biotech (PBYI)

7.07 +0.05 (0.71%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/30/26)
- M&A (Rumor)

Latest Headlines

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) June 3, 2026 5:00 PM - BizWire Puma Biotech (PBYI) Misses Q1 EPS by 4c, provides guidance May 7, 2026 4:46 PM - StreetInsider Form 10-Q PUMA BIOTECHNOLOGY, INC. For: Mar 31 May 7, 2026 4:41 PM - SEC Filing Form 8-K PUMA BIOTECHNOLOGY, INC. For: May 07 May 7, 2026 4:35 PM - SEC Filing Puma Biotechnology Reports First Quarter 2026 Financial Results May 7, 2026 4:05 PM - BizWire Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) May 6, 2026 5:15 PM - BizWire Form DEFA14A PUMA BIOTECHNOLOGY, INC. April 28, 2026 4:20 PM - SEC Filing Form ARS PUMA BIOTECHNOLOGY, INC. For: Dec 31 April 28, 2026 4:20 PM - SEC Filing Form DEF 14A PUMA BIOTECHNOLOGY, INC. For: Jun 11 April 28, 2026 4:16 PM - SEC Filing Puma Biotechnology to Host Conference Call to Discuss First Quarter 2026 Financial Results April 23, 2026 4:15 PM - BizWire Form PRE 14A PUMA BIOTECHNOLOGY, INC. For: Jun 11 April 7, 2026 5:13 PM - SEC Filing Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) April 2, 2026 5:15 PM - BizWire Form SCHEDULE 13G/A PUMA BIOTECHNOLOGY, INC. Filed by: VANGUARD GROUP INC March 27, 2026 11:38 AM - SEC Filing Full Article List